Inogen (INGN) EBITDA Margin (2013 - 2026)
Inogen's (INGN) quarterly EBITDA Margin came in at 5.36% in Q2 2026, up 128.0% year-over-year from 2.35% in Q2 2025, and up 51.14% quarter-over-quarter from 10.97% in Q1 2026.
Powered by 
Analysis
Inogen (INGN) EBITDA Margin (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported EBITDA Margin for 14 consecutive years, with 5.36% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 128.0% year-over-year to 5.36% in Q2 2026; TTM through Jun 2026 was 8.71%, a 89.0% increase from a year earlier, with the FY2025 full-year figure at 8.66%, up 400.0% from the prior year.
- EBITDA Margin was 5.36% for Q2 2026 at Inogen, up from 10.97% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2.78% in Q2 2022 and troughed at 66.4% in Q4 2022.
- A 5-year average of 18.74% and a median of 11.18% in 2025 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 5766 bps in 2022 and surged 4687 bps in 2024, its largest moves.
- Over 5 years, EBITDA Margin stood at 66.4% in 2022, then jumped by 42 bps to 38.19% in 2023, then surged by 63 bps to 14.22% in 2024, then advanced by 20 bps to 11.39% in 2025, then soared by 53 bps to 5.36% in 2026.
- The last three EBITDA Margin figures came in at 5.36% (Q2 2026), 10.97% (Q1 2026), and 11.39% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | -5.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.36% |
| Mar 31, 2026 | -10.97% |
| Dec 31, 2025 | -11.39% |
| Sep 30, 2025 | -7.70% |
| Jun 30, 2025 | -6.64% |
| Mar 31, 2025 | -9.30% |
| Dec 31, 2024 | -14.22% |
| Sep 30, 2024 | -8.77% |
| Jun 30, 2024 | -7.96% |
| Mar 31, 2024 | -20.86% |
| Dec 31, 2023 | -38.19% |
| Sep 30, 2023 | -55.64% |
| Jun 30, 2023 | -14.07% |
| Mar 31, 2023 | -30.37% |
| Dec 31, 2022 | -66.40% |
| Sep 30, 2022 | -9.77% |
| Jun 30, 2022 | -2.78% |
| Mar 31, 2022 | -16.90% |
| Dec 31, 2021 | -8.73% |
| Sep 30, 2021 | 6.85% |